Leadership & Pay ·
NovaBridge Biosciences appointed Martin Dewhurst as an independent director and member of the Audit and Compensation…
IMABNovaBridge Biosciences
NovaBridge Biosciences appointed Martin Dewhurst as an independent director and member of the Audit and Compensation Committees on September 8, 2026. Mr. Dewhurst brings over 30 years of healthcare leadership experience, including co-leading McKinsey’s Global Life Sciences Practice and serving on multiple biotechnology boards. His appointment follows the departure of independent director Liu Xin from the Board. NovaBridge Biosciences is a global biotechnology company advancing therapeutic programs in oncology and ophthalmology.